Are these high-flying ASX shares buys today?

Pro Medicus is one of the ASX shares that has been flying higher. Are they buys?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There is a small group of ASX shares that have performed really strongly for shareholders recently, delivering impressive operational results and market-beating share price growth.

However, whilst it's possible for some share prices to be good value, it is also possible that some excellent businesses to run ahead too hard.

So, after a strong run, are these two ASX shares worth looking at?

asx investor daydreaming about US shares

Image source: Getty Images

Pro Medicus Ltd (ASX: PME)

Pro Medicus describes itself as a leading healthcare informatics business. It provides a full range of medical imaging software and services to hospitals, imaging centres and healthcare groups globally. It offers a "clinically rich" and highly scalable cloud platform that can be used for both public and private environments.

The Pro Medicus share price has soared 84% over the last year.

This ASX share has been winning many large contracts with healthcare clients. One of the most recent wins was the 7-year, $40 million contract with Novant Health. Pro Medicus' Visage software will replace multiple picture archiving and communication systems (PACs).

Novant Health joined an increasing number of Visage clients that are opting for a fully cloud based solution.

Despite winning a number of contracts, Pro Medicus says that its pipeline remains strong in both North America and other regions. FY21 was a big year of growth – revenue rose 19.5% to $67.9 million, underlying profit before tax increased 41% to $42.6 million and the earnings before interest and tax (EBIT) margin improved to 63.2%.

Opinions are somewhat mixed on Pro Medicus. Morgans rates the ASX share as a hold, with a price target of $54.49.

However, Citi thinks Pro Medicus is a sell with a price target of just $45 – that's almost 30% lower than where it is now. It's concerned about cheaper competition in the future and that the market is being too bullish about the potential strength of the company's success.

Aussie Broadband Ltd (ASX: ABB)

This telecommunications business has also had a year strong year. Over the last 12 months it has gone up by 136%.

Aussie Broadband continues to see growth of its broadband user base.

At 30 September 2021 it had 445,780 broadband services. By 30 December 2021 it's expecting to have at least 482,495 services which includes expected organic net additions of at least 38,000. That's organic growth of at least 8.5% quarter on quarter.

A recent focus of both analysts and the company has been the expected acquisition of Over The Wire Holdings Ltd (ASX: OTW). This combination is predicted to deliver annual cost synergies of $8 million to $12 million within three years, ongoing capital expenditure savings and significant acceleration of capabilities of the group.

This proposed transaction, which will be funded by both cash and new shares, is expected to add to earnings per share (EPS) on both a pre and post synergy FY21 basis.

Ord Minnett is a fan of the deal, as it would grow the company's offering into other categories.  It rates Aussie Broadband as a buy, with a price target of $5.91.

Credit Suisse's price target of $5.40 also offers potential double upside, but the broker is only 'neutral' on the business.

Ord Minnett thinks that the Aussie Broadband share price is valued at 34x FY23's estimated earnings.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Aussie Broadband Limited, Over The Wire Holdings Ltd, and Pro Medicus Ltd. The Motley Fool Australia owns and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended Aussie Broadband Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Why this beaten down $9 billion ASX 200 share is now a buy

A leading expert believes AI will help, rather than hinder, this tech focused ASX 200 stock.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Buy, hold, sell: Collins Foods, Liontown, and Northern Star shares

Morgans has given its verdict on these top shares.

Read more »

A young boy sits on top of a big rubber bouncing ball with handles as he smiles a toothless grin at the camera and bounces above the ground in a grassy field with a blue sky.
Broker Notes

Two ASX shares on the rebound

Brokers suggest the rebound can continue.

Read more »

a mature but cool older woman holds a watering can and tends to a healthy green plant growing up the wall in her house.
Broker Notes

Bell Potter just initiated coverage on this ASX utilities stock with a buy recommendation

This under the radar company could be worth watching.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

3 reasons to buy QBE shares today

A leading analyst expects QBE shares to outperform. Let’s see why.

Read more »

Broker looking at the share price.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

man looks at phone while disappointed
Broker Notes

What are analysts saying about ResMed, Downer, and Nuix shares?

They have given their verdicts on these shares. Are they bullish or bearish? Here's what you need to know.

Read more »

A U.S. Naval Ship (DDG) enters Sydney harbour.
Broker Notes

Why it's not too late to buy this surging ASX All Ords defence stock

A top broker expects more outperformance from this rocketing ASX defence stock.

Read more »